{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T01:33:14Z","timestamp":1793496794101,"version":"4.5.0"},"reference-count":43,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,2,6]],"date-time":"2021-02-06T00:00:00Z","timestamp":1612569600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004326","name":"Bayer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004326","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004737","name":"National Health Research Institutes","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004737","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006484","name":"Vifor Pharma","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006484","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health Research","doi-asserted-by":"publisher","award":["12\/206\/52"],"award-info":[{"award-number":["12\/206\/52"]}],"id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health Research","doi-asserted-by":"publisher","award":["G1002033"],"award-info":[{"award-number":["G1002033"]}],"id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health Research","doi-asserted-by":"publisher","award":["MR\/N022556\/1"],"award-info":[{"award-number":["MR\/N022556\/1"]}],"id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000848","name":"University of Edinburgh","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000848","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003358","name":"Gedeon Richter","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003358","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000855","name":"University of Birmingham","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000855","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","fertstert.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Fertility and Sterility"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.fertnstert.2021.02.008","type":"journal-article","created":{"date-parts":[[2021,4,14]],"date-time":"2021-04-14T18:03:17Z","timestamp":1618423397000},"page":"882-895","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["The endometrial response to modulation of ligand-progesterone receptor pathways is reversible"],"prefix":"10.1016","volume":"116","author":[{"given":"Rohan R.","family":"Chodankar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3719-3291","authenticated-orcid":false,"given":"Alison","family":"Murray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moira","family":"Nicol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucy H.R.","family":"Whitaker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alistair R.W.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hilary O.D.","family":"Critchley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.fertnstert.2021.02.008_bib1","series-title":"National Institute for Health and Care Excellence","article-title":"NG88: heavy menstrual bleeding: assessment and management","year":"2018"},{"key":"10.1016\/j.fertnstert.2021.02.008_bib2","first-page":"359","article-title":"An epidemiological survey of symptoms of menstrual loss in the community","volume":"54","author":"Shapley","year":"2004","journal-title":"Br J Gen Pract"},{"key":"10.1016\/j.fertnstert.2021.02.008_bib3","first-page":"502","article-title":"Physiological action of progesterone in target tissues","volume":"18","author":"Graham","year":"1997","journal-title":"Endocr Rev"},{"key":"10.1016\/j.fertnstert.2021.02.008_bib4","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1055\/s-0031-1287664","article-title":"Molecular and cellular causes of abnormal uterine bleeding of endometrial origin","volume":"29","author":"Critchley","year":"2011","journal-title":"Semin Reprod Med"},{"key":"10.1016\/j.fertnstert.2021.02.008_bib5","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1093\/humupd\/dmv038","article-title":"Menstrual physiology: implications for endometrial pathology and beyond","volume":"21","author":"Maybin","year":"2015","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.fertnstert.2021.02.008_bib6","doi-asserted-by":"crossref","first-page":"35079","DOI":"10.1074\/jbc.M111.273029","article-title":"Structural basis for agonism and antagonism for a set of chemically related progesterone receptor modulators","volume":"286","author":"Lusher","year":"2011","journal-title":"J Biol Chem"},{"key":"10.1016\/j.fertnstert.2021.02.008_bib9","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/0010-7824(86)90055-7","article-title":"Therapeutic abortion in early pregnancy with antiprogestogen RU486 alone or in combination with prostaglandin analogue (gemeprost)","volume":"34","author":"Cameron","year":"1986","journal-title":"Contraception"},{"key":"10.1016\/j.fertnstert.2021.02.008_bib10","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.contraception.2012.06.011","article-title":"First-trimester medical abortion with mifepristone 200 mg and misoprostol: a systematic review","volume":"87","author":"Raymond","year":"2013","journal-title":"Contraception"},{"key":"10.1016\/j.fertnstert.2021.02.008_bib12","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1097\/PGP.0b013e318251035b","article-title":"Endometrial morphology after treatment of uterine fibroids with the selective progesterone receptor modulator, ulipristal acetate","volume":"31","author":"Williams","year":"2012","journal-title":"Int J Gynecol Pathol"},{"key":"10.1016\/j.fertnstert.2021.02.008_bib13","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.ejogrb.2017.04.042","article-title":"Endometrial changes during ulipristal acetate use: a systematic review","volume":"214","author":"De Milliano","year":"2017","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.fertnstert.2021.02.008_bib14","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0173523","article-title":"Safety after extended repeated use of ulipristal acetate for uterine fibroids","volume":"12","author":"Fauser","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.fertnstert.2021.02.008_bib15","doi-asserted-by":"crossref","first-page":"3582","DOI":"10.1210\/jc.2006-2816","article-title":"Effects of the progesterone receptor modulator VA2914 in a continuous low dose on the hypothalamic-pituitary-ovarian axis and endometrium in normal women: a prospective, randomized, placebo-controlled trial","volume":"92","author":"Chabbert-Buffet","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2021.02.008_bib16","first-page":"531","article-title":"Selective progesterone receptor modulator (SPRM) ulipristal acetate (UPA) and its effects on the human endometrium","volume":"32","author":"Whitaker","year":"2017","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2021.02.008_bib17","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1093\/humrep\/dem026","article-title":"The effects of the selective progesterone receptor modulator asoprisnil on the morphology of uterine tissues after 3 months treatment in patients with symptomatic uterine leiomyomata","volume":"22","author":"Williams","year":"2007","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2021.02.008_bib18","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1080\/14728222.2016.1180368","article-title":"Selective progesterone receptor modulators (SPRMs): progesterone receptor action, mode of action on the endometrium and treatment options in gynecological therapies","volume":"20","author":"Wagenfeld","year":"2016","journal-title":"Expert Opin Ther Targets"},{"key":"10.1016\/j.fertnstert.2021.02.008_bib19","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.fertnstert.2015.04.025","article-title":"In\u00a0vivo mechanisms of uterine myoma volume reduction with ulipristal acetate treatment","volume":"104","author":"Courtoy","year":"2015","journal-title":"Fertil Steril"},{"issue":"Suppl","key":"10.1016\/j.fertnstert.2021.02.008_bib20","doi-asserted-by":"crossref","first-page":"e140","DOI":"10.1016\/j.fertnstert.2018.07.415","article-title":"Molecular mechanisms responsible for myoma volume reduction after ulipristal acetate","volume":"110","author":"Donnez","year":"2018","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2021.02.008_bib21","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1210\/jc.2004-1569","article-title":"Progesterone receptor modulator CDB-2914 down-regulates proliferative cell nuclear antigen and Bcl-2 protein expression and up-regulates caspase-3 and poly(adenosine 5'-diphosphate-ribose) polymerase expression in cultured human uterine leiomyoma cells","volume":"90","author":"Xu","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2021.02.008_bib22","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1016\/S0015-0282(98)00029-6","article-title":"Chronic antiprogestin therapy produces a stable atrophic endometrium with decreased fibroblast growth factor: a 1-year primate study on contraception and amenorrhea","volume":"69","author":"Grow","year":"1998","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2021.02.008_bib23","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.rbmo.2018.12.013","article-title":"Absence of predictable long-term molecular effect of ulipristal acetate (UPA) on the endometrium","volume":"38","author":"Kolanska","year":"2019","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.fertnstert.2021.02.008_bib24","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0015-0282(16)30062-0","article-title":"Dating the endometrial biopsy","volume":"1","author":"Noyes","year":"1950","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2021.02.008_bib25","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ijgo.2010.11.011","article-title":"FIGO classification system (PALM-COEIN) for causes of abnormal uterine bleeding in nongravid women of reproductive age","volume":"113","author":"Munro","year":"2011","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.fertnstert.2021.02.008_bib26","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1002\/ijgo.12666","article-title":"The two FIGO systems for normal and abnormal uterine bleeding symptoms and classification of causes of abnormal uterine bleeding in the reproductive years: 2018 revisions","volume":"143","author":"Munro","year":"2018","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.fertnstert.2021.02.008_bib27","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1042\/bj3131007","article-title":"Cloning and production of antisera to human placental 11 beta-hydroxysteroid dehydrogenase type 2","volume":"313","author":"Brown","year":"1996","journal-title":"Biochem J"},{"key":"10.1016\/j.fertnstert.2021.02.008_bib28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-017-17204-5","article-title":"QuPath: open source software for digital pathology image analysis","volume":"7","author":"Bankhead","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.fertnstert.2021.02.008_bib29","doi-asserted-by":"crossref","first-page":"E1802","DOI":"10.1210\/jc.2013-2140","article-title":"Endometrial intracrinology--generation of an estrogen-dominated microenvironment in the secretory phase of women","volume":"98","author":"Gibson","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2021.02.008_bib30","doi-asserted-by":"crossref","first-page":"3276","DOI":"10.3390\/ijms19103276","article-title":"Endometrial intracrinology: oestrogens, androgens and endometrial disorders","volume":"19","author":"Gibson","year":"2018","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.fertnstert.2021.02.008_bib31","first-page":"913","article-title":"The effects of an antiprogestin, mifepristone, and an antiestrogen, tamoxifen, on endometrial 17 beta-hydroxysteroid dehydrogenase and progestin and estrogen receptors during the luteal phase of the menstrual cycle: an immunohistochemical study","volume":"77","author":"M\u00e4entausta","year":"1993","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2021.02.008_bib32","doi-asserted-by":"crossref","first-page":"4315","DOI":"10.1210\/jc.2004-2338","article-title":"Leukocyte populations and steroid receptor expression in human first-trimester decidua; regulation by antiprogestin and prostaglandin E analog","volume":"90","author":"Milne","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2021.02.008_bib33","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1210\/jc.2002-021763","article-title":"Flutamide counteracts the antiproliferative effects of antiprogestins in the primate endometrium","volume":"88","author":"Slayden","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2021.02.008_bib34","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/bjc.2015.453","article-title":"Measuring the biological effect of presurgical metformin treatment in endometrial cancer","volume":"114","author":"Sivalingam","year":"2016","journal-title":"Br J Cancer"},{"key":"10.1016\/j.fertnstert.2021.02.008_bib35","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1006\/excr.2000.4888","article-title":"The Ki-67 protein: fascinating forms and an unknown function","volume":"257","author":"Endl","year":"2000","journal-title":"Exp Cell Res"},{"key":"10.1016\/j.fertnstert.2021.02.008_bib36","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.4049\/jimmunol.133.4.1710","article-title":"Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67","volume":"133","author":"Gerdes","year":"1984","journal-title":"J Immunol"},{"key":"10.1016\/j.fertnstert.2021.02.008_bib37","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1093\/humrep\/den494","article-title":"Effect of asoprisnil on uterine proliferation markers and endometrial expression of the tumour suppressor gene, PTEN","volume":"24","author":"Wilkens","year":"2009","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2021.02.008_bib38","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1210\/clinem\/dgz139","article-title":"The selective progesterone receptor modulator ulipristal acetate inhibits the activity of the glucocorticoid receptor","volume":"105","author":"Small","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2021.02.008_bib39","doi-asserted-by":"crossref","first-page":"2312","DOI":"10.1093\/humrep\/del182","article-title":"Mifepristone-induced amenorrhoea is associated with an increase in microvessel density and glucocorticoid receptor and a decrease in stromal vascular endothelial growth factor","volume":"21","author":"Narvekar","year":"2006","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2021.02.008_bib40","doi-asserted-by":"crossref","first-page":"2832","DOI":"10.1161\/hc4801.100077","article-title":"Endothelial cell dysfunction in mice after transgenic knockout of type 2, but not\u00a0type 1, 11beta-hydroxysteroid dehydrogenase","volume":"104","author":"Hadoke","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.fertnstert.2021.02.008_bib41","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1196\/annals.1366.030","article-title":"Local amplification of glucocorticoids by 11beta-hydroxysteroid dehydrogenase type 1 and its role in the inflammatory response","volume":"1088","author":"Chapman","year":"2006","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.fertnstert.2021.02.008_bib42","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1126\/science.1197454","article-title":"The antiproliferative action of progesterone in uterine epithelium is mediated by Hand2","volume":"331","author":"Li","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.fertnstert.2021.02.008_bib43","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1210\/me.2001-0154","article-title":"Identification of Indian hedgehog as a progesterone-responsive gene in the murine uterus","volume":"16","author":"Takamoto","year":"2002","journal-title":"Mol Endocrinol"},{"key":"10.1016\/j.fertnstert.2021.02.008_bib44","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1172\/JCI1597","article-title":"HOXA10 is expressed in response to sex steroids at the time of implantation in the human endometrium","volume":"101","author":"Taylor","year":"1998","journal-title":"J Clin Invest"},{"key":"10.1016\/j.fertnstert.2021.02.008_bib45","doi-asserted-by":"crossref","first-page":"13735","DOI":"10.1038\/srep13735","article-title":"FoxM1 directs STAT3 expression essential for human endometrial stromal decidualization","volume":"5","author":"Jiang","year":"2015","journal-title":"Sci Rep"},{"key":"10.1016\/j.fertnstert.2021.02.008_bib46","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0960-0760(96)00113-6","article-title":"Endometrial effects of RU486 in primates\u2014antiproliferative action despite signs of estrogen action and increased cyclin-B expression","volume":"59","author":"Heikinheimo","year":"1996","journal-title":"J Steroid Biochem Mol Biol"}],"container-title":["Fertility and Sterility"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028221001254?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028221001254?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T06:16:47Z","timestamp":1762150607000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0015028221001254"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":43,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["S0015028221001254"],"URL":"https:\/\/doi.org\/10.1016\/j.fertnstert.2021.02.008","relation":{},"ISSN":["0015-0282"],"issn-type":[{"value":"0015-0282","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The endometrial response to modulation of ligand-progesterone receptor pathways is reversible","name":"articletitle","label":"Article Title"},{"value":"Fertility and Sterility","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.fertnstert.2021.02.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a92021 The Authors. Published by Elsevier Inc. on behalf of the American Society for Reproductive Medicine.","name":"copyright","label":"Copyright"}]}}